申请人:Boehringer Ingelheim International GmbH
公开号:US08299111B2
公开(公告)日:2012-10-30
Compounds of formula (I)
are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.
公式(I)的化合物被披露。该发明的化合物与CB2受体结合并且是激动剂、拮抗剂或反向激动剂,可用于治疗炎症。那些是激动剂的化合物还可用于治疗疼痛。